Canaccord initiated coverage of Wave Life Sciences (WVE) with a Buy rating and $19 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Oppenheimer Predicts Up to 590% Rally for These 2 ‘Strong Buy’ Stocks
- Wave Life Sciences Poised for Growth: Buy Rating Affirmed Amid Upcoming Catalysts
- Wave Life Sciences Earnings Call: Clinical Advances Amid Financial Challenges
- Wave Life Sciences Advances RNA Medicine Pipeline
- Wave Life Sciences reports Q2 EPS (31c), consensus (28c)